WhatsApp +86 130 1285 6649
TRISANA MEDGUIDEFOR MEDICAL TOURISM IN CHINA
Home / Medical Care in China / Hematology

Medical Care in China

Hematology

It covers treatment areas such as common hematological diseases, malignant hematological diseases, hematopoietic stem cell transplantation, and CAR-T therapy.

Get a Care Plan and Cost Estimate
The coverage of blood diseases is broadincluding anemia, leukemia, lymphoma, and myeloma.
Precise blood diagnosisclarifies the condition through bone marrow, molecular and genetic examinations.
Cell therapy selectionCAR-T and other therapies are evaluated for eligible patients.
Transplantation therapy supportcovers hematopoietic stem cell transplantation and related management.

Diagnostic Range

Discover the treatment pathway that's right for you

Select a category to see information on care plans, matching hospitals, specialists, and more.

Anemia (aplastic anemia, iron deficiency anemia, severe β-thalassemia)

Disease Introduction Anemia refers to a group of diseases characterized by a lower than normal number of red blood cells or hemoglobin in peripheral blood, resulting in insufficient tissue oxygen supply. Aplastic anemia is caused by bone marrow failure leading to a pancytopenia, manifesting as anemia, bleeding, and infection; iron deficiency anemia is caused by insufficient iron reserves leading to impaired hemoglobin synthesis, often caused by blood loss or insufficient intake; severe β-thalassemia is c

leukemia

Disease Introduction Leukemia is a hematologic malignancy caused by the malignant clonal proliferation of hematopoietic stem and progenitor cells. Based on cell origin, it is classified into acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL, more common in children), and chronic myeloid leukemia (CML). Typical manifestations include anemia, bleeding, fever and infection, bone pain, and enlargement of the liver, spleen, and lymph nodes. The cure rate for childhood beta-angiocarcinoma (B-ALL)

Lymphoma

Disease Introduction Lymphoma is a malignant tumor originating from lymphocytes, and is divided into two main categories: Hodgkin's lymphoma and non-Hodgkin's lymphoma. Common subtypes of the latter include diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and mantle cell lymphoma. Typical symptoms include painless lymphadenopathy, which may be accompanied by fever, night sweats, weight loss (B symptoms), and hepatosplenomegaly. Modern treatment is based on immunochemotherapy, combined with targ

Multiple myeloma

Disease Introduction Multiple myeloma is a hematologic malignancy caused by the malignant proliferation of plasma cells, manifesting as bone pain, pathological fractures, anemia, kidney damage, hypercalcemia, and recurrent infections. It is highly prevalent in the elderly population. While a complete cure is currently difficult, the emergence of drugs such as proteasome inhibitors, immunomodulators, CD38 monoclonal antibodies, dual antibodies, and CAR-T therapy has ushered in an era of long-term managemen

Primary immune thrombocytopenic purpura

Disease Introduction Primary immune thrombocytopenic purpura (ITP) is a hemorrhagic disease caused by increased platelet destruction and insufficient platelet production mediated by the autoimmune system. Symptoms include petechiae and ecchymoses on the skin, bleeding gums, and nosebleeds; in severe cases, internal bleeding may occur. It is more common in adults as a chronic condition, while in children it is more often acute. The treatment goal is to raise the platelet count to a safe level and reduce th

Allergic purpura

Disease Introduction Allergic purpura (IgA vasculitis) is a vasculitis characterized by the deposition of IgA immune complexes in small blood vessels. It is more common in children and typically presents as symmetrical purpura on the skin. It may be accompanied by joint swelling and pain, abdominal pain, gastrointestinal bleeding, and kidney involvement (IgA vasculitis nephritis). Most cases are self-limiting, but kidney involvement is a key factor affecting long-term prognosis and requires standardized f

Network of partner hospitals

Recommended Hospitals

Selected leading medical centers with strong specialties and international patient services.

Institute of Hematology, Chinese Academy of Medical Sciences (Chinese Academy of Medical Sciences Institute of Hematology)
Institute of Hematology, Chinese Academy of Medical Sciences (Chinese Academy of Medical Sciences Institute of Hematology) logo
Beijing · Partner Hospital

Institute of Hematology, Chinese Academy of Medical Sciences (Chinese Academy of Medical Sciences Institute of Hematology)

Hematology

The institute is the supporting unit of the National Clinical Research Center for Hematological Diseases, the National Stem Cell Engineering Technology Research Center, and the Stem Cell Medicine Center of the Chinese Academy of Medical Sciences. It is also the executive department of the World Federation of Hemophilia (China), the supporting unit of the National Hemophilia Case Information Management Center, and is leading the establishment of the National Quality Control Center for Hematology. For many consecutive years, it has ranked first in the Fudan University ranking of hematology disciplines, and its CAR-T cell therapy center for hematological diseases ranks second in the country.

Year Founded
1957
Beds
1540
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo
Shanghai · Partner Hospital

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

OncologyHematologyGastroenterologyUrologyInternal MedicineSurgeryOrthopedics

Ruijin Hospital consistently ranks among the top four hospitals in China according to the comprehensive hospital rankings released by the Fudan University Hospital Management Institute. It is a national medical center construction unit and possesses national-level platforms such as the National Clinical Research Center for Metabolic Diseases and the National Clinical Research Center for Hematological Diseases. The hospital currently has four key disciplines designated by the Ministry of Education (Hematology, Endocrinology and Metabolic Diseases, Cardiology, and Neurology), 22 national key clinical specialties, and one national key laboratory for medical genomics. The hospital has been awarded the title of National Civilized Unit four times consecutively and has received honors such as the National May 1st Labor Medal and the National Advanced Collective of the Health System. It is also a national demonstration unit for integrated traditional Chinese and Western medicine.

Year Founded
1907
Beds
5100
Southern Medical University Southern Hospital
Southern Medical University Southern Hospital logo
Guangzhou · Partner Hospital

Southern Medical University Southern Hospital

Organ TransplantHematologyInternal MedicineCosmetic Surgery

The hospital is a national regional trauma medical center jointly constructed by the provincial and national governments, a national project unit for improving the diagnosis and treatment capabilities of difficult and complex diseases (tumors), a national regional TCM (rheumatology) treatment center, a national emergency medical rescue base, and one of the first key construction units in Guangdong Province's "Peak Climbing Plan" for high-level hospitals. It boasts 5 national key disciplines, 17 national key clinical specialties, and 4 national key clinical specialty construction projects. In the 2023 national public hospital performance evaluation, it ranked in the A+ category. In authoritative domestic hospital rankings, the hospital consistently ranks among the top 15 to 20 comprehensive hospitals nationwide, with more than ten specialties, including nephrology, infectious diseases, plastic surgery, hematology, pathology, and gastroenterology, ranking in the top ten or receiving nominations.

Year Founded
1941
Beds
2225
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology logo
Wuhan · Partner Hospital

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

HematologyCardio-CerebrovascularUrology

The hospital ranks 9th nationwide in the Fudan University China Hospital Specialty Ranking, making it one of the strongest hospitals in Central China. Its specialties, including heart transplantation, hematology, ultrasound, nuclear medicine, anesthesiology, and cardiovascular surgery, are among the top in the country. In particular, its nuclear medicine department has consistently ranked among the top two in Fudan University's specialty rankings for many years, and its heart transplant volume has ranked first in the country for many consecutive years. The hospital is a national drug clinical trial institution and a national stem cell clinical research institution, boasting strong research capabilities.

Year Founded
1866
Beds
6000

Leading Specialists

Trusted Expertise Across Leading Specialties

Feng Ru

Feng Ru

Professor, Chief Physician, Doctoral Supervisor, Deputy Director of Department, Head of Lymphoma Subspecialty

Hematology

-Research areas : pathogenesis, diagnosis and treatment of lymphoma and multiple myeloma, targeted immunotherapy, and leukemia. - Cutting-edge technologies: Dynamic monitoring of MRD for lymphoma and myeloma, and clinical research on new drugs for relapsed and refractory lymphomas. - Areas of expertise: Hodgkin's/non-Hodgkin's lymphoma, multiple myeloma, plasma cell diseases, lymphoma, leukemia. - Academic Highlights & Value: Visiting scholar experience in the United States and Japan; presided over multip

Southern Medical University Southern Hospital logo Affiliated Hospital Southern Medical University Southern Hospital
Sun Jing

Sun Jing

Professor, Chief Physician, Doctoral Supervisor, Deputy Director of Department, Director of Hemophilia Center

Hematology

-Research areas : Hematopoietic stem cell transplantation, bleeding disorders, and hemophilia diagnosis and treatment - Cutting-edge technologies: unrelated hematopoietic stem cell transplantation, hemophilia inhibitor immune tolerance induction program/comprehensive diagnosis and treatment of hemophilia and inhibitor management (the largest hemophilia center in South China), prevention and treatment of transplant complications. - Areas of expertise: Hemophilia, von Willebrand disease, platelet disorders,

Southern Medical University Southern Hospital logo Affiliated Hospital Southern Medical University Southern Hospital
Zhang Xiaobing

Zhang Xiaobing

Researcher, doctoral supervisor, head of the cell gene transformation platform

Hematology

Research areas : gene editing, CAR vector design, iPSC, LNP delivery technology; Cutting-edge technologies: CRISPR gene editing CAR cells, GMP construction of lentiviral vectors; Areas of expertise: CAR vector development, gene therapy; Academic highlights: National high-level talent, multiple cell therapy invention patents; Core value: Supporting the research and clinical translation of underlying vector technologies for CAR-T and gene therapy.

Institute of Hematology, Chinese Academy of Medical Sciences (Chinese Academy of Medical Sciences Institute of Hematology) logo Affiliated Hospital Institute of Hematology, Chinese Academy of Medical Sciences (Chinese Academy of Medical Sciences Institute of Hematology)
Zhao Weili

Zhao Weili

Chief Physician, Level 2 Professor, Doctoral Supervisor, Director of Shanghai Institute of Hematology, Vice President of Ruijin Hospital

Hematology

-Research areas : lymphoma immunotherapy, CAR-T cell therapy clinical research, and real-world CAR-T studies in Asian populations. - Cutting-edge technologies: CAR-T stratified treatment system for relapsed and refractory large B-cell lymphoma; CAR-T adverse reaction MDT management model. - Areas of expertise: Diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma, follicular lymphoma, and other B-cell non-Hodgkin lymphomas. - Academic Highlights: Led a multicenter real-world study of CAR-T th

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Liu Qifa

Liu Qifa

Level 2 Professor, Chief Physician, Doctoral Supervisor, Academic Leader, Director of the Institute of Hematology

Hematology

Research areas : Molecular pathogenesis of leukemia, hematopoietic stem cell transplantation, tumor immunotherapy, and prevention and treatment of infections in immunocompromised hosts. - Cutting-edge technologies: Haploidentical hematopoietic stem cell transplantation; MICM precision stratification therapy for leukemia; precision stratification therapy for acute leukemia (rewriting the NCCN/ELN guidelines); combined haploidentical and umbilical cord blood transplantation (Lancet RCT); MSC prevention of G

Southern Medical University Southern Hospital logo Affiliated Hospital Southern Medical University Southern Hospital
Li Junmin

Li Junmin

Head of Hematology

Hematology

Research areas : hematologic malignancies and hematologic immune diseases; construction of CAR-T clinical research system. Cutting-edge technology: creation of translational medicine wards and CAR-T clinical trial screening system. Specializes in treating: acute myeloid leukemia, multiple myeloma, and lymphoma. Academic Highlights: Led the establishment of China's first translational medicine ward in hematology; emphasized that CAR-T "is a novel immunotherapy that acts on the tumor microenvironment and ha

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Service Process

A clear, coordinated process for efficient cross-border care

  1. 01

    Pre-Visit Services

    Contact us for help organising and translating medical records, planning consultations, and finding suitable hospitals and specialists.

  2. 02

    Remote Consultations

    A remote consultation helps establish an initial approach to diagnosis and treatment, with a cost estimate available within 48 hours.

  3. 03

    Travel Arrangements

    We assist with visa applications, book flights and hotel or apartment accommodation, and arrange airport pick-up, private transport and check-in.

  4. 04

    Comprehensive Support in China

    We accompany you to medical appointments and provide interpreting services, help arrange specialist consultations or surgery, assist with hospital admission and discharge, and help settle medical bills.

  5. 05

    Post-Visit Services

    We assist with notarisation of medical expense documents, airport drop-off, organisation and translation of medical records, remote rehabilitation guidance, and coordination of international referrals.

Patient Stories

See the Next Step Through Patient Journeys

Lower Extremity Arteriosclerosis Obliterans - A Masterpiece for Unblocking the CASE 01
PATIENT JOURNEY

Lower Extremity Arteriosclerosis Obliterans - A Masterpiece for Unblocking the "Silent Killer"

HematologyCardio-Cerebrovascular

Patient records Name: Carlos Silva Age: 70 Nationality: Brazil (São Paulo) Diagnosis: Lower extremity arteriosclerosis obliterans (Rutherford grade 4, long segment occlusion of the left superficial femoral artery, rest pain) Treatment Hospital: Department of Vascular Surgery, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Mr. Carlos is a passionate samba dancer who, even in his seventies, still enjoys swaying to the music on the streets of Rio. However, for the past six mo

View case details →
Lymphoma : While CAR-T therapy is prohibitively expensive and has long waiting times in the West: An Australian patient found an accessible CASE 02
PATIENT JOURNEY

Lymphoma : While CAR-T therapy is prohibitively expensive and has long waiting times in the West: An Australian patient found an accessible "cure" in China.

OncologyHematology

Patient records Name: Sarah Age: 32 Nationality: Australia Diagnosis: Relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL), non-germinal center type (non-GCB), CD19 positive, relapsed after autologous stem cell transplantation. Treatment Hospital: Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Tianjin) In the field of cancer treatment, CAR-T cell therapy is hailed as "living medicine," bringing hope of a cure to patients with relapsed or refractory hemat

View case details →
When CAR-T CASE 03
PATIENT JOURNEY

When CAR-T "Failed": How a Singaporean child found a backup plan in China Patient records

Hematology

Name: Ethan (pseudonym) Age: 8 years old Nationality: Singapore Diagnosis: Relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL), CD19-negative relapse after CD19 CAR-T therapy. Treatment Hospital: Shanghai Children's Medical Center In the field of childhood leukemia treatment, CAR-T cell therapy has brought hope to countless families. But when this "living drug" also fails, patients' families face an abyss of near despair. Ethan's story tells how we helped a family find a "backup plan" with

View case details →

Frequently Asked Questions

Hematology FAQs

Learn about clinical review, record preparation and arrangements for care in China.

Talk to Our Care Team →
Which blood diseases are suitable for treatment in China?

These include leukemia, lymphoma, multiple myeloma, aplastic anemia, etc.

Which patients are suitable for CAR-T?

It is mainly for patients with specific hematologic malignancies who meet the indications and require professional evaluation.

What needs to be done before CAR-T treatment?

Usually, a comprehensive assessment of the disease status, physical condition, and related indicators is required.

Can CAR-T therapy treat solid tumors?

Currently, its clinical applications and indications are mainly concentrated on some hematologic malignancies, and specific evaluations need to be based on the latest medical standards.

Currently, its clinical applications and indications are mainly concentrated on some hematologic malignancies, and specific evaluations need to be bas

Donor selection depends on the patient's condition and can be professionally evaluated by the transplant center.

Can leukemia relapsed patients still receive treatment?

Some relapsed patients can still be evaluated for treatment options such as medication, cell therapy, or transplantation.

Can people with thalassemia undergo hematopoietic stem cell transplantation?

Some patients who meet the criteria can be evaluated for transplantation.

Can I have a remote consultation before treatment?

You can submit your medical records, bone marrow examination data, and treatment information for a preliminary assessment.

How long is the treatment period for blood diseases?

The time required varies greatly depending on the disease and treatment plan, and needs to be determined based on the specific plan.

What kind of follow-up is needed after returning to China?

Usually, regular blood routine tests, bone marrow examinations, or related disease indicators are required, and remote expert follow-up can be combined.